Michael J. Fox Foundation signs up for wearable-enabled Phase III trial project

The Michael J. Fox Foundation (MJFF) has furthered its drive to establish wearable devices as part of the data-gathering toolkit in clinical trials of Parkinson's treatments. Cynapsus is collaborating with MJFF on the inclusion of a wearable-enabled sub-study in its Phase III trial. The alliance builds on a deal MJFF struck with Intel in 2014, which set out to improve the monitoring of Parkinson's patients between site visits through the use of wearable devices. Release

Suggested Articles

There's no evidence personal patient information leaked during the 11-week breach, but the same can't be said about Sangamo's own secrets.

Through a new online tracker, AllTrials names sponsors who fail to report clinical trial results on time per the FDAAA Final Rule.

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.